Northcliff Provides Update on Sisson Project Feasibility Study and Environmental Assessment
VANCOUVER, Oct. 11, 2012 /CNW/ - Northcliff Resources Ltd. ("Northcliff" or the "Company") (TSX: NCF) announces an update on current studies underway on its 100% owned Sisson Tungsten-Molybdenum Project located in New Brunswick, Canada.
Feasibility Study
The Sisson Project Feasibility Study, which is being prepared by Samuel Engineering, Inc. of Denver, Colorado, is nearing completion. The Company plans to announce the results by mid-November 2012, following which the Company will have 45 days to file the corresponding NI 43-101 technical report on SEDAR (www.sedar.com).
Environmental Assessment and Permitting
The Environmental Impact Assessment (EIA) report, which is being prepared by Stantec Inc., of Fredericton, New Brunswick, remains on track for completion in November 2012 and subsequent submission to both Federal and Provincial governments. Concurrent with the review of the EIA, the Company plans to begin preparing for permit and mining license applications.
Financing
Over the past several months, Northcliff has begun the process of engaging with potential strategic partners to assess their interest in participating in the Sisson Project. The Company expects that this process will continue through the end of 2012 and into 2013.
Northcliff President and CEO Christopher Zahovskis said, "I am pleased with the progress that has been made since Northcliff started work on the Sisson Project just two years ago. We set out an ambitious schedule at that time with an overall objective of completing the feasibility study by the fall of this year. With the upswing in the tungsten market over the same period, we have remained focused on advancing Sisson into the feasibility stage as quickly as possible to provide tremendous potential value to our shareholders."
About Northcliff
Northcliff is a mineral resource company associated with Hunter Dickinson Inc. (HDI), and focused on progressing the feasibility-stage Sisson Tungsten-Molybdenum Project located in New Brunswick, Canada, to production.
Christopher Zahovskis
President & CEO
No regulatory authority accepts responsibility for the adequacy or accuracy of this release.
This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address completion of the Acquisition, permitting, exploration drilling, exploitation activities and events or developments that the company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include uncertainty of shareholder support, the need for judicial and regulatory approvals, market prices, exploitation and exploration successes, continuity of mineralization, potential environmental issues and liabilities associated with exploration, development and mining activities, uncertainties related to the ability to obtain necessary permits, licenses and title and delays due to third party opposition, changes in government policies regarding mining and natural resource exploration and exploitation, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, investors should review the Company's continuous disclosure filings that are available at www.sedar.com.
SOURCE Northcliff Resources Ltd.
on Northcliff and the Sisson Project, please visit www.northcliffresources.com or contact Investor Services at (604) 684-6365 or within North America at 1-800-667-2114.